Guo-hua Li
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
AviNP-Seq: A Blindspot-Free Single-Molecule Framework for Unmasking AAV Genome Heterogeneity and Determining Packaging Limits.
Journal: Human gene therapy
Published: June 12, 2026
Author Correction: Efficient precise knockin with a double cut HDR donor after CRISPR/Cas9-mediated double-stranded DNA cleavage.
Journal: Genome biology
Published: May 28, 2025
Biomembrane-inspired lipid nanoparticles enhance CRISPR-Cas9 editing for hemophilia A.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: May 23, 2025
Enhancing hemophilia A gene therapy by strategic F8 deletions in AAV vectors.
Journal: Blood science (Baltimore, Md.)
Published: July 20, 2024
A p21 reporter iPSC line for evaluating CRISPR-Cas9 and vector-induced stress responses.
Journal: Stem cells (Dayton, Ohio)
Published: May 02, 2024
Improved and Flexible HDR Editing by Targeting Introns in iPSCs.
Journal: Stem cell reviews and reports
Published: January 10, 2022
GREPore-seq: A Robust Workflow to Detect Changes After Gene Editing Through Long-range PCR and Nanopore Sequencing.
Journal: Genomics, proteomics & bioinformatics
Published: August 18, 2021
Curing hemophilia A by NHEJ-mediated ectopic F8 insertion in the mouse.
Journal: Genome biology
Published: September 12, 2019
Highly efficient genome editing via CRISPR-Cas9 in human pluripotent stem cells is achieved by transient BCL-XL overexpression.
Journal: Nucleic acids research
Published: March 29, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026